June 7, 2021
Mayo Clinic Research in the news — 6/7/2021
By Advancing the Science contributor
Mayo Clinic research and faculty experts are cited by media outlets on a range of topics this week including the newly-approved Alzheimer’s drug (Monday, 6/7/2021), a new treatment for multiple myeloma and another for precocious puberty, as well as remote patient monitoring and other timely topics. Alzheimer’s Drug Poses a Dilemma for the F.D.A. The […]
Tags: Alzheimer's disease, autonomic nervous system, cardiovascular medicine, Chia-Chun Chiang, clinical informatics, clinical research, clinical trials, COVID-19, Cris Ross, David Knopman, DeLisa Fairweather, FDA
February 22, 2021
Mayo Clinic Research in the news — 2/22/2021
Over the last week, Mayo Clinic researchers and expertise have been cited in wide range of news stories, from the ever present COVID-19 to telehealth, participation in cancer clinical trials, creatine supplements, artificial intelligence and more. Read on for headlines, excerpts and links. Telehealth research & key resources: Research findings American Medical Association, 2/19/2021 Telehealth […]
Tags: Andrew Jagim, angioplasty, artificial intelligence, Bernard Gersh, blood pressure, Brian Pickering, cancer, CAR-T cell therapy, cardiology, cardiovascular medicine, clinical trials, COVID-19
January 28, 2016
Pharmaceutical Pricing and Marketing: Markets vs. Regulation Seminar
By Lois Krahn
The cost of medications is becoming a major threat to patients seeking treatment for disease, and the problem appears to be growing. What role a free market system and competition should play in a commercial area regulated by government regulation including patents is difficult to gauge. Patients and advocacy groups are calling for more awareness of […]
Tags: Arizona State University, Center for the Science of Health Care Delivery, pharmacy, Rafael Fonseca